# Trade Mark Journal No.2026/011 13 March 2026

## WO0000001904479 (5,42,44)

Office of origin: United States of America

Date of International Registration:23 January 2026
Date of designation in the UK: 23 January 2026

International priority date claimed: 16 January 2026 (United States of America) (99599373)

Class 5
  Pharmaceutical preparations for the treatment of oncological diseases and disorders; radiopharmaceutical preparations for the treatment of cancer; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; radio-isotope markers for therapeutic or diagnostic use; diagnostic radiopharmaceutical preparations; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for suppressing tumors.
Class 42
  Medical and scientific research in the field of oncological disorders; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research information in the field of pharmaceuticals and clinical trials.
Class 44
  Providing medical information via a website; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals.

EndPath Radiotherapeutics, Inc.

Representative: Makiko Coffland Christensen O'Connor Johnson Kindness PLLC, 1201 Third Avenue, Suite 3600, Seattle WA 98101, UNITED STATES OF AMERICA